Michael J. McGinley, Presi, Biologic. & Pharm at HESKA CORP (HSKA), sold 6,914 shares at $35.00 ($244K) on 2015-11-17, disclosed to the SEC on 2015-11-19.
Open-market sale of $244k HSKA by Presi, Biologic. & Pharm. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.00 | 100 | $4K | 1.4% |
| 2 | $35.03 | 200 | $7K | 2.9% |
| 3 | $35.06 | 200 | $7K | 2.9% |
| 4 | $35.07 | 300 | $11K | 4.3% |
| 5 | $35.09 | 100 | $4K | 1.4% |
| 6 | $35.10 | 100 |
| $4K |
| 1.4% |
| 7 | $35.13 | 100 | $4K | 1.4% |
| 8 | $35.23 | 99 | $3K | 1.4% |
| 9 | $35.25 | 100 | $4K | 1.4% |
| 10 | $35.26 | 100 | $4K | 1.4% |
| 11 | $35.30 | 2,400 | $85K | 34.7% |
| 12 | $35.31 | 600 | $21K | 8.7% |
| 13 | $35.31 | 200 | $7K | 2.9% |
| 14 | $35.32 | 300 | $11K | 4.3% |
| 15 | $35.33 | 100 | $4K | 1.4% |
| 16 | $35.34 | 400 | $14K | 5.8% |
| 17 | $35.35 | 15 | $530 | 0.2% |
| 18 | $35.36 | 200 | $7K | 2.9% |
| 19 | $35.36 | 600 | $21K | 8.7% |
| 20 | $35.37 | 400 | $14K | 5.8% |
| 21 | $35.38 | 100 | $4K | 1.5% |
| 22 | $35.40 | 100 | $4K | 1.5% |
| 23 | $35.41 | 100 | $4K | 1.5% |
| Total | $35.28 avg | 6,914 | $244K | 100% |
| Filing → |
| HSKA | SELL | 2017-06-01 | $2.2M | — | Filing → |
| HSKA | SELL | 2016-11-09 | $729K | — | Filing → |
| HSKA | SELL | 2016-05-10 | $219K | — | Filing → |